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Abstract It is known for many years that heritability plays
a role in the development of endometriosis in many
patients. Deep endometriosis of the bladder is a rare
presentation of the disease and bladder endometriosis was
not reported in monozygotic twin studies so far. Since
monozygotic twins share the same genes, concordance and
differences in presentation of endometriosis may help to
discriminate between genetic and environmental determi-
nants. The remarkable resemblance in the presentation of
bladder endometriosis in this monozygotic twin seems to
indicate that genetic factors are of importance in the arising




Endometriosis affects 6–10% of women in their reproduc-
tive years and affects up to 35–50% of women with pain or
infertility [1]. Urogenital tract is superficially involved in
about 10–15% of cases but deep endometriosis of the
bladder is estimated to be present in 1–2% of the patients
only [2–5] Bladder endometriosis is frequently accompa-
nied by other forms of pelvic endometriosis [4]. Frequency,
urgency, suprapubic pain and dysuria [3, 6, 7] are the most
frequent symptoms of bladder endometriosis and a positive
correlation between severity of dysuria and lesion diameter
has been described [7]. Haematuria seems to be a less
frequent symptom in 20–35% of patients [2, 3, 6].
Heritability of endometriosis is well known from twin
studies for many years, but this concerned mainly the
increased risk to develop endometriosis and deep bladder
endometriosis was not mentioned [8–11]. Despite the rare
occurrence of bladder endometriosis, a monozygotic twin
presented at our clinic with similar complaints and
remarkable resemblance in the presentation of disease.
Case report
A 33-year-old Caucasian woman, G0P0, was referred to our
department for relapse of endometriosis after previous
surgery and hormonal treatment elsewhere. Although she
did not have a relation at the moment, she wanted to
preserve fertility. Dysmenorrhoea was acceptable with a
levonorgestrel containing IUD in situ, but dysuria was
increasing. Four years ago, she had a first laparoscopic
local excision of endometriosis. Two years later, a re-
excision took place followed by treatment with LHRH
analogue for half a year. She was heterozygote for factor V
Leiden without a history of thrombosis or embolism. Recto-
vaginal examination revealed an enlarged and somewhat
irregular painful uterus without vaginal or rectal involve-
ment. IUD was in situ. At transvaginal ultrasound a round-
shaped mass of about 1.5 cm was protruding from the
uterus into the roof of the bladder. The ovaries had a normal
appearance. There was no haematuria and urine culture was
negative. Since the placement of the progesterone contain-
ing IUD a year before, the Ca 125 level decreased from 266
to a level varying from 97 to 116 kU/l. IVP showed a
dimple in the roof of the bladder and excluded an
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e-mail: jvbeek2@viecuri.nlobstruction of the ureters. The magnetic resonance imaging
(MRI) scan showed an adenomyotic uterus with one lesion
protruding in the backside of the bladder. The recto-vaginal
septum was not involved and ovaries were normal. To plan
surgery, an examination under general anaesthesia was
scheduled. At cystoscopy, the protruding lesion was seen in
the top of the bladder covered with endothelium and well
away from the ureters. At laparoscopy (Fig. 1), the bladder
attached densely to the adenomyotic uterus and superficial
endometriosis was visible at the backside of the uterus.
Further, there were no peritoneal implants, and the ovaries
were normal.
Some months later, her monozygotic G0 twin sister
presented with dysuria and dyschezia during bleeding
periods. As a monozygotic twin sister, she was hetero-
zygote factor V Leiden too without a history of thrombosis
or embolism. She never had child wish and she had a
levonorgestrel containing IUD 1 year earlier in life. She
hardly suffered from dysmenorrhoea. At recto-vaginal
examination, a firm nodule was palpable at the right
sacro-uterine ligament; the uterus was of normal size and
mobility. Haematuria was absent and Ca 125 was 50 kU/l.
MRI scan (Fig. 2) revealed a normal uterus with a single
nodule protruding in the backside of the bladder likewise as
her sister. At the backside of the cervix, superficial
endometriosis was visible but recto-vaginal septum was
free of disease. Further, there were no plaques of
endometriosis. At cystoscopy a nodule was seen at exact
the same position as seen in her sister (Fig. 3). At
laparoscopy, the uterus was normal, but the bladder was
attached to the uterus with an implant of endometriosis
present at the backside of the cervix comparable to the
picture of her sister. There were no other spots of
endometriosis intra-abdominally.
Because of the predominant complaint of dysuria, both
sisters were planned for laparoscopic excision of the
bladder nodule by partial cystectomy and excision of
the lesion at the backside of the cervix. After excision, the
bladder was closed with a running suture vicryl 3×0.
Complete closure of the bladder was tested with instillation
of 150 ml methylene blue dye solution into the bladder at
the end of the procedure. Since the sister with adenomyosis
wanted to preserve fertility, her uterus was left in situ. The
uterus of the sister without child wish was normal.
Levonorgestrel IUD remained in situ in both. Prophylactic
antibiotics were given for 24 h. Postoperative course was
uneventful in both sisters. They were discharged the day
after surgery with indwelling catheter. The bladder catheter
was removed after a week and micturation proved normal
afterwards. Histology confirmed in both cases an adeno-
myotic lesion through the bladder wall covered with normal
bladder endothelium.
At follow-up visit after 6 weeks, dysuria had disappeared
in both. At follow-up so far, the sister with the adenomyosis
has some dysmenorrhoea still but bearable without pain
medication. Her sister has no more complaints at all.
Discussion
Dysmenorrhoea, cyclic dysuria and suprapubic pain are the
most frequent reported symptoms related to bladder
endometriosis in literature [2, 3, 6]. In both our patients,
dysuria was the predominant complaint with dysmenor-
rhoea as a second complaint. The dyschezia reported by one
of the sisters was probably due to the nodule behind the
cervix. Although the bowel was not involved, the complaint
had disappeared after resection. The fact that the endo-
metriotic lesions of both sisters were still covered with
urothelium will explain the absence of haematuria. This is
in agreement with the literature [2, 5].
Ultrasound is the simplest first step in diagnosis of
endometriosis. Combination of abdominal, transvaginal and
Fig. 1 Laparoscopic view of patient 1. Firm adhesions around an
adenomyotic uterus
Fig. 2 MRI scan of patient 2. Endometriosis nodule protruding in the
top of the bladder and a second lesion behind the cervix
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reveal endometriosis in infrequent sites [12]. In urogenital
endometriosis, the bladder is the most frequent involved
organ and superficial endometriosis of the bladder is often
part of more extended endometriosis [13]. Ultrasound may
also be used as a first step to exclude obstruction of the
ureters. Although a dimple in the bladder was clear, an IVP
is not the first choice to diagnose bladder disease. In case of
suspicion of obstruction, however, it may help to localise
the place and extent of the obstruction. MRI scanning is
more sensitive to diagnose preoperatively the extent of
endometriosis especially for retroperitoneal disease and
bowel involvement [5, 14]. Cystoscopy and laparoscopy are
required for definitive diagnosis [15].
The pathogenesis of bladder endometriosis has not been
clarified. Donnez et al. proposed metaplasia from mullerian
remnants [13], but the histological evidence of mullerian
remnants in the urothelium of the bladder has been doubted
[4]. Transplantation theory considers the extension of
adenomyotic lesions and transport through blood and
lymphatic vessels [16]. Finally, post surgery implantation,
mainly after Caesarean, may be responsible in a part of the
cases [13, 16]. Both twin sisters of this study had
adenomyotic lesions of the bladder but only one of the
sisters had further adenomyosis.
Urogenital endometriosis is much more frequent than
deep bladder endometriosis [17]. Bladder endometriosis is
frequently accompanied by other forms of endometriosis
but bladder endometriosis and ureter endometriosis are not
associated [4, 18]. Patients with ureter endometriosis
usually have more advanced disease [5, 17, 18]. Therefore,
the deep endometriosis of the bladder seems to be a
different entity within advanced endometriosis.
Genetic factors play a part in the development of
endometriosis but inheritance is complex. It is well known
that family members of patients with endometriosis have an
increased risk to develop endometriosis [10, 19]. The UK–
Australian twin examination estimated 51% of the expres-
sion to be attributable to genetic factors [11]. The risks
between monozygotic twins have been estimated as high as
75–87% [8, 9]. However, this concerned the change of
endometriosis for relatives and a correlation in severity, but
the localization of the endometriosis often differed between
the twin pairs and bladder endometriosis was not described.
Bladder endometriosis was mentioned neither in the large
genome wide linkage study [11] nor in the genetic studies
of Bischoff [19]. The lesions in the bladder and behind the
cervix in the monozygotic twin described here were
identical and there were no further peritoneal implants.
The development of endometriosis is multi-factorial and
the presentation depends on genetic and extrinsic factors
[19]. Apart from resemblance, our twin sisters showed
discrepancies too. One of them had fewer complaints, had
not been operated on before and had no further adenomyo-
sis. She never had child wish and the levonorgestrel-
releasing IUD had been placed about 1 year earlier in her
life. It seems unlikely that the short time difference in the
placement of the progesterone containing IUD explains the
difference in adenomyosis between the sisters. The IUD
had not prevented the progression of the bladder and the
retro-cervical endometriosis in either of them. Evidence for
a beneficial effect of a levonorgestrel-releasing IUD is still
limited at this moment [20]. The sister with adenomyosis
had been operated on incompletely twice. If this may cause
extension of the adenomyosis is unlikely, but no other
differences between the sisters is available from their
medical histories. Inheritance is complex [1, 10, 19].
Presumably, different genes may influence the development
in different ways as by influencing retrograde menstruation,
cell differentiation, hormonal misbalance and by detoxifi-
cation processes [1, 19]. Although this may explain the
wide variation in expression of endometriosis, it cannot
explain differences in our monozygotic twin.
Symptomatic lesions can be treated hormonally or by
surgery. Hormonal treatment for pain will postpone child
wish and overall does not improve fertility. It may have
different side effects dependant of the medication chosen
[21]. For small lesions and in women near menopause
hormonal treatment may be considered. For larger and
deeper lesions (>5 mm) surgery is recommended generally
Fig. 3 Bladder nodule of
patient 1 (left) and of patient
2( right), localised in the roof
of the bladder
Gynecol Surg (2010) 7:375–378 377[2, 3, 17]. Hormonal treatment resulted in temporary relief
of symptoms only and previous surgery proved to be
inadequate in the first of the twin sisters presented here. In
the second sister, the levonorgestrel IUD controlled
dysmenorrhoea reasonably but dysuria and dyschezia
increased. Radical excision of the lesions relieved all her
symptoms. Especially in younger women, surgical treat-
ment of bladder endometriosis should be first choice
treatment.
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